- Home
- OSUR vs CRMD Comparison
OSUR vs CRMD Comparison
Compare OSUR & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- CRMD
- Stock Information
- Founded
- OSUR 2000
- CRMD 2006
- Country
- OSUR United States
- CRMD United States
- Employees
- OSUR N/A
- CRMD N/A
- Industry
- OSUR Medical/Dental Instruments
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- OSUR Health Care
- CRMD Health Care
- Exchange
- OSUR Nasdaq
- CRMD Nasdaq
- Market Cap
- OSUR 334.1M
- CRMD 279.7M
- IPO Year
- OSUR 1986
- CRMD 2010
- Fundamental
- Price
- OSUR $4.13
- CRMD $12.04
- Analyst Decision
- OSUR Buy
- CRMD Strong Buy
- Analyst Count
- OSUR 3
- CRMD 5
- Target Price
- OSUR $6.67
- CRMD $13.60
- AVG Volume (30 Days)
- OSUR 459.6K
- CRMD 909.2K
- Earning Date
- OSUR 11-05-2024
- CRMD 11-12-2024
- Dividend Yield
- OSUR N/A
- CRMD N/A
- EPS Growth
- OSUR N/A
- CRMD N/A
- EPS
- OSUR 0.36
- CRMD N/A
- Revenue
- OSUR $273,535,000.00
- CRMD $806,119.00
- Revenue This Year
- OSUR N/A
- CRMD N/A
- Revenue Next Year
- OSUR N/A
- CRMD $206.77
- P/E Ratio
- OSUR $11.35
- CRMD N/A
- Revenue Growth
- OSUR N/A
- CRMD 2107.40
- 52 Week Low
- OSUR $3.92
- CRMD $2.57
- 52 Week High
- OSUR $8.45
- CRMD $12.07
- Technical
- Relative Strength Index (RSI)
- OSUR 45.49
- CRMD 90.23
- Support Level
- OSUR $4.00
- CRMD $9.67
- Resistance Level
- OSUR $4.16
- CRMD $10.66
- Average True Range (ATR)
- OSUR 0.08
- CRMD 0.51
- MACD
- OSUR 0.01
- CRMD 0.14
- Stochastic Oscillator
- OSUR 57.89
- CRMD 98.48
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.